Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

ROCK

Rho-associated protein kinase (ROCK) is a kinase belonging to the AGC (PKA/ PKG/PKC) family of serine-threonine kinases. It is involved mainly in regulating the shape and movement of cells by acting on the cytoskeleton.

  • Y-27632 dihydrochloride
    T1725129830-38-2
    Y-27632 dihydrochloride (Y-27632 2HCl) is an orally potent, ATP-competitive inhibitor of ROCK-I and ROCK-II. Y-27632 dihydrochloride also inhibits isolation-induced apoptosis in mouse prostate stem or progenitor cells.
    • $39
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • Y-27632
    T1870146986-50-7
    Y-27632 (Y-27632) is an orally potent, ATP-competitive inhibitor of ROCK-I and ROCK-II. Y-27632 also inhibits isolation-induced apoptosis in mouse prostate stem or progenitor cells.
    • $39
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • Netarsudil Dihydrochloride
    T103581253952-02-1
    Netarsudil Dihydrochloride (AR-13324 Dihydrochloride) is an inhibitor of Rho-associated protein kinase (ROCK) and norepinephrine transporter (NET) with effective in intraocular pressure (IOP) reduction.
    • $96
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
  • Thiazovivin
    T21551226056-71-8
    Thiazovivin, a ROCK inhibitor (IC50: 0.5 μM), increases the survival rate of hESC.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Fasudil
    T1606103745-39-7
    Fasudil (HA-1077) is a potent inhibitor of ROCK1, PKA, PKC, and MLCK.
    • $33
    In Stock
    Size
    QTY
  • CID-5056270
    T23888681173-76-2In house
    CID-5056270 has anticancer activity and can inhibit lung cancer, anal cancer, bladder cancer, cervical cancer, vulvar cancer, penile cancer, Burkitt's lymphoma, breast cancer and bone cancer. It can be used to study hypertension, Alzheimer's disease and arteriosclerosis.
    • $329
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • GKI-1 HCl
    T11402L In house
    GKI-1 HCl is a Greatwall (GWL) kinase inhibitor that inhibits hGWLFL and hGWL-KinDom.The inhibitory effect of GKI-1 HCl on ROCK1 is more significant.
    • $161
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • WAY-656935
    T77609852902-81-9
    WAY-656935 inhibits ROCK.
    • $45
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Rhodblock 6
    T26078886625-06-5
    Rhodblock 6 is a Rho kinase (ROCK) inhibitor that inhibits the localization of phosphorylated MRLC (Myosin Regulatory Light Chain) and acts by specifically inhibiting Rho kinase activity.
    • $106
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • SB-747651A Dihydrochloride
    T96521781882-72-1In house
    SB-747651A dihydrochloride is a chemical compound that serves as an ATP-competitive inhibitor for mitogen- and stress-activated kinase 1 (MSK1), featuring an IC50 of 11 nM. Additionally, this compound effectively inhibits PRK2, RSK1, p70S6K, and ROCK-II, showcasing its potential in inflammation research [1].
    • $67
    In Stock
    Size
    QTY
  • ROCK-IN-5
    T67748692870-25-0In house
    ROCK-IN-5 (compound I-B-37) is a potent inhibitor of protein kinases, including ROCK, ERK, GSK, and AGC. ROCK-IN-5 exhibits the potential for cardiac, proliferative and neurodegenerative diseases research.
    • $38
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • CRT0066854 hydrochloride
    T108882250019-91-9In house
    CRT0066854 hydrochloride is an effective selective atypical PKCs inhibitor. CRT0066854 is against full-length (FL) PKCι, PKCζ, and ROCK-II kinases with IC50 values of 132 nM, 639 nM, and 620 nM, respectively.
    • $33
    In Stock
    Size
    QTY
  • H-1152 dihydrochloride
    T35328871543-07-6In house
    H-1152 dihydrochloride (H-1152 2HCl) is a specific inhibitor of Rho-associated protein kinase (ROCK) with an IC50 of 12 nM and a Ki of 1.6 nM. H-1152 dihydrochloride inhibits PKA, PKC, PKG, Aurora A and CaMKII with IC50 values of 3.03 μM, 5.68 μM, 0.360 μM, 0.745 μM and 0.180 μM, respectively.
    • $58
    In Stock
    Size
    QTY
  • Rho-Kinase-IN-1
    T127211035094-83-7In house
    Rho-Kinase-IN-1 is an inhibitor of ROCK with Kis of 30.5 nM and 3.9 nM for ROCK1 and ROCK2, respectively. Rho-Kinase-IN-1 can be used in studies about excessive cell proliferation, remodeling, edema and inflammation diseases.
    • $135
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Chroman 1
    T149601273579-40-0In house
    Chroman 1 is an inhibitor of ROCK2 (IC50: 1 nM).
    • $70
    In Stock
    Size
    QTY
  • LX7101
    T157981192189-69-7In house
    LX7101 is an effective inhibitor of LIMK and ROCK2 (IC50: 24, 1.6, and 10 nM for LIMK1, LIMK2, and ROCK2, respectively). It also inhibits PKA (IC50 <1 nM).
    • $56
    In Stock
    Size
    QTY
  • GSK-25
    T4488874119-56-9
    GSK-25 maintains good selectivity against a panel of 31 kinases, as well as RSK1 and p70S6K (RSK1 IC50 of 398 nM, p70S6K IC50 of 1000nM), and a dramatically improved P450 profile (>2.2 uM at all isozymes tested).
    • $39
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Hydroxyfasudil Hydrochloride
    T4276155558-32-0
    Hydroxyfasudil Hydrochloride (HA 1100 hydrochloride) is a ROCK1/2 inhibitor (IC50s: 0.73/0.72 μM).
    • $34
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Tofacitinib
    T6321477600-75-2
    Tofacitinib (Tasocitinib) is an oral, small molecule inhibitor of Janus kinases that is used to treat moderate-to-severe rheumatoid arthritis.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Afuresertib
    T19111047644-62-1
    Afuresertib (GSK2110183) is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity.
    • $33
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Fasudil hydrochloride
    T3060105628-07-7
    Fasudil hydrochloride (HA-1077) is a potent inhibitor of ROCK1, PKA, PKC, and MLCK with Ki of 0.33 μM, 1.0 μM, 9.3 μM and 55 μM, respectively.
    • $35
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Ripasudil
    TQ0319887375-67-9
    Ripasudil (Ripasudil hydrochloride dihydrate) (K-115) hydrochloride dihydrate is a specific ROCK inhibitor (IC50s: 51/19 nM for ROCK1/ROCK2).
    • $64
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • GSK269962A
    T3518850664-21-0
    GSK269962A (GSK269962A HCl) is a selective ROCK(Rho-associated protein kinase) inhibitor with IC50 values of 1.6 and 4 nM for ROCK1 and ROCK2, respectively.
    • $36
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • LX-7101 hydrochloride
    T329851374644-80-0
    LX-7101 hydrochloride is a potent LIMK and ROCK2 inhibitor with antihypertensive activity, inhibits LIMK1/2, ROCK, PKA, and can be used to study glaucoma.
    • $195
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ROCK2-IN-2
    T127471995065-79-6
    ROCK2-IN-2 is a selective inhibitor of ROCK2 (IC50 of <1 μM).
    • $84
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Cucurbitacin A
    TN15336040-19-3
    Cucurbitacin I, cytotoxic triterpenoid sterols isolated from plants, elicits the formation of actin/phospho-myosin II co-aggregates by stimulation of the RhoA/ROCK pathway and inhibition of LIM-Kinase.
    • $998
    Backorder
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ROCK2-IN-7
    T812613000541-95-4
    ROCK2 inhibitor is a chemical compound associated with the therapeutic management of psoriasis. It exhibits its efficacy in targeting ROCK2 enzymes within HaCaT cells and has demonstrated beneficial effects in a psoriasis-like mouse model.
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • CCG-232964
    T827662349373-70-0
    CCG-232964 is an orally active Rho/MRTF/SRF inhibitor that suppresses LPA-induced CTGF gene expression [1].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • ROCK2-IN-6
    T798322260506-59-8
    ROCK2-IN-6 (Comp A) is a selective inhibitor of ROCK2, applicable in the study and treatment of ROCK-mediated, autoimmune, and inflammatory diseases [1].
    • Inquiry Price
    Size
    QTY
  • ROCK-IN-8
    T798091621103-79-4
    ROCK-IN-8 (Example 4), a ROCK inhibitor, exhibits anti-inflammatory properties and is suitable for respiratory and gastro-intestinal disease research, demonstrating an IC50 value below 100 nM [1].
    • Inquiry Price
    Size
    QTY
  • Y-9738
    T1397259399-41-6
    Y-9738 is an agent of hypolipidemic.
    • $1,520
    Backorder
    Size
    QTY
  • CMPD101
    T14989865608-11-3
    CMPD101 is a membrane-permeable small-molecule inhibitor of GRK2/3 (IC50: 18 nM and 5.4 nM). Which can be used for the study of heart failure. CMPD101 exhibits less selectively against GRK1, GRK5, ROCK-2 and PKCα with IC50s of 3.1 μM , 2.3 μM, 1.4 μM and 8.1 μM, respectively.
    • $60
    In Stock
    Size
    QTY
  • ROCK inhibitor-2
    T127461127308-52-4
    ROCK inhibitor-2 is a selective dual inhibitor of ROCK1 and ROCK2 (IC50s of 17 nM and 2 nM, respectively).
    • $60
    In Stock
    Size
    QTY
  • CAY10746
    T361962247240-76-0
    CAY10746 is a selective Rho kinase (ROCK) inhibitor that inhibits ROCK I and ROCK II with IC50 values of 0.014 μM and 0.003 μM, respectively.CAY10746 can be used to study diabetic retinopathy.
    • $52
    In Stock
    Size
    QTY
  • Akt/ROCK-IN-1
    T79905
    Akt/ROCK-IN-1 (B12) is a dual inhibitor targeting Akt and ROCK, exhibiting IC50 values of 0.023 nM and 1.47 nM, respectively. It possesses antitumor efficacy against neuroblastoma [1].
    • Inquiry Price
    Size
    QTY
  • Hydroxyfasudil
    T4276L105628-72-6
    Hydroxyfasudil (Hydroxy-Fasudil) is a ROCK inhibitor(IC50s of 0.73 and 0.72 μM for ROCK1 and ROCK2, respectively).
    • $35
    In Stock
    Size
    QTY
  • Ripasudil free base
    T7492223645-67-8
    Ripasudil free base (K-115 (free base)) is a selective and potent ROCK inhibitor, is a novel and potent antiglaucoma agent.
    • $73
    Backorder
    Size
    QTY
  • AT13148
    T24821056901-62-2
    AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.
    • $41
    In Stock
    Size
    QTY
  • Narciclasine
    TQ018329477-83-6
    Narciclasine (Lycoricidinol), a natural product, modulates the Rho/Rho-kinase/LIM kinase/cofilin signaling pathway, greatly increasing GTPase RhoA activity.
    • $97
    In Stock
    Size
    QTY
  • AS 1892802
    T22037928320-12-1
    AS 1892802 is a potent and selective inhibitor of ROCK. AS 1892802 exibits IC50 values of 52nM, 57nM and 122 nM for human ROCK2, rat ROCK2 and human ROCK1, respectively. The onset of antinociceptive effect of AS 1892802 is as fast as those of Tramadol and Diclofenac.
    • $44
    In Stock
    Size
    QTY
  • Y-33075 dihydrochloride
    T13384L173897-44-4
    Y-33075 dihydrochloride is a selective inhibitor of ROCK(IC50 of 3.6 nM).
    • $38
    In Stock
    Size
    QTY
  • RKI-1447
    T18981342278-01-6
    RKI-1447 is a potent inhibitor of ROCK1 and ROCK2. It has anti-invasive and antitumor activities.
    • $47
    In Stock
    Size
    QTY
  • Merestinib dihydrochloride
    T158081206801-37-7
    Merestinib dihydrochloride is an effective and orally bioavailable c-Met inhibitor (Ki=2 nM). It has anti-tumor activities and also has potent activity against MST1R (IC50=11 nM), FLT3 (IC50=7 nM), AXL (IC50=2 nM), MERTK (IC50=10 nM), TEK (IC50=63 nM), RO
    • $62
    5 days
    Size
    QTY
  • Cotosudil
    T386541258833-31-6
    Cotosudil is a ROCK kinase inhibitor with antihypertensive activity and is used to treat or prevent diseases or conditions caused by cataracts, cardiovascular or neurodegenerative diseases or nerve damage.
    • $106
    In Stock
    Size
    QTY
  • SR-3677
    TQ01871072959-67-1
    SR-3677 is an effective and specific inhibitor of ROCK2 (IC50: 3 nM).
    • $30
    In Stock
    Size
    QTY
  • Verosudil
    T609241414854-42-4
    Verosudil (AR-12286) is a highly potent Rho kinase (ROCK) inhibitor with a Ki of 2 and 2 nM against ROCK1 and ROCK2, respectively. AR-12286 reverses steroid-induced intraocular pressure in mice by decreasing intraocular pressure by increasing outflow of aqueous ether through the trabecular reticulum.
    • $89
    In Stock
    Size
    QTY
  • ROCK-IN-7
    T790802376635-95-7
    ROCK-IN-7 (compound 9) serves as a ROCK kinase inhibitor and is utilized in the investigation of ocular conditions, including glaucoma and retinal diseases [1].
    • Inquiry Price
    Size
    QTY
  • ROCK-IN-9
    T798332643334-76-1
    ROCK-IN-9 (Compound T345), a ROCK inhibitor, exhibits cytotoxicity in HepG2 cells with an IC50 of 40.8 μM. It demonstrates favorable pharmacokinetic properties in mice, achieving high in vivo exposure and oral bioavailability at low doses [1].
    • Inquiry Price
    Size
    QTY
  • Belumosudil
    T6867911417-87-3
    Belumosudil (Rezurock) is an orally available, and specific ROCK2 inhibitor (IC50/Ki: 60/41 nM).
    • $41
    In Stock
    Size
    QTY
  • ROCK-IN-1
    T13419934387-35-6
    ROCK-IN-1 is a potent ROCK inhibitor that inhibits ROCK2-mediated signaling with an IC50 value of 1.2 nM.ROCK-IN-1 can be used in the study of neurological disorders and inflammation-related diseases.
    • $119
    Backorder
    Size
    QTY